摘要
目的:观察应用XIVE种植体行口腔种植治疗并同期植入珊瑚羟基磷灰石(CHA)的临床效果。方法:12例患者在使用XIVE种植系统进行口腔种植修复时,应用成品珊瑚羟基磷灰石作为同期骨增量治疗的植入材料。结果:术后随访全部病例均无全身性异常反应,术后创口愈合良好,无异物排出现象,种植体稳定度好。X线片显示植入3月后珊瑚骨密度逐渐降低,而珊瑚骨之间的空隙密度增高,6～9个月珊瑚羟基磷灰石基本完全吸收。结论:珊瑚羟基磷灰石具有良好的生物相容性和骨诱导性,在应用XIVE种植体时可作为同期植入的骨增量植入材料。
Objective： To observe the clinical effect of one-stage implantation of coralline hydroxyapatite with XIVE implants. Method： 12 cases of one-stage implantation of coralline hydroxyapatite with XIVE implants were studied retrospective. The clinic symptoms implanted with CHA and X-ray film were observed to evaluated the bone healing. Result： No general abnormal reactions were found in following up. The incisions were healed. The density of CHA gradually reduced from 3 months.The stability of implants were satisfied. The CHA was nearly campletely absorbed 6～9 months post-operation. Conclusion：The CHA is an ideal bone graft material for its good clinic results and favourable histocompatlbility in the treatment of one-stage implantation with XIVE implants.
出处
《临床口腔医学杂志》
2008年第8期479-480,共2页
Journal of Clinical Stomatology
